Using Massage to Reduce Use of Sedative-Hypnotic Drugs With Older Adults A Brief Report From a Pilot Study

被引:3
|
作者
Nelson, Rhonda [1 ]
Coyle, Catherine [1 ]
机构
[1] Temple Univ, Coll Hlth Profess, CTRS, Philadelphia, PA 19122 USA
关键词
elderly; sleep disturbances; massage; complementary and alternative medicine; nonpharmacological interventions; sedative-hypnotic drugs; SLEEP; CARE;
D O I
10.1177/07334648093355941
中图分类号
R4 [临床医学]; R592 [老年病学];
学科分类号
1002 ; 100203 ; 100602 ;
摘要
Despite known adverse effects, sedative-hypnotic drugs (SHDs) are widely used in institutional settings serving the elderly. Using a 2 (Intervention, Control) x 3 (Baseline, Intervention, Withdrawal) mixed design with random assignment to the intervention (n = 15) or control (n = 13) group, the authors sought to determine if a nonpharmacological sleep intervention (massage at bedtime) could reduce "as-needed" SHD (PRN-SHD) usage. Each phase of this pilot lasted 7 days and PRN-SHD usage was monitored via chart review. Results, indicating a 13% greater reduction in requests for PRN-SHD for the intervention group when it received massage, approached statistical significance for the quadratic planned comparisons (p = .17) despite limited power (.28) for the observed effect size of .07. While preliminary, results suggest that massage at bedtime may reduce PRN-SHD usage with older adults. Randomized controlled studies with larger samples are needed.
引用
收藏
页码:129 / 139
页数:11
相关论文
共 38 条
  • [31] Clinical Implementation of Pharmacogenomics Testing to Guide P2Y12 Inhibitor Use in Older Adults With Acute Coronary Syndrome: Insights From a Prospective Pilot Study
    Sakya, Sagune
    Regan, Christopher J.
    Picot-Vierra, Lionel
    Riello, Ralph J.
    Tran, Lydia
    Schulz, Wade
    Smolderen, Kim G.
    Mena-Hurtado, Carlos
    Pulk, Rebecca
    CIRCULATION, 2020, 142
  • [32] Assessing tobacco use in Swedish young adults from self-report and urinary cotinine: a validation study using the BAMSE birth cohort
    Zettergren, Anna
    Sompa, Shanzina
    Palmberg, Lena
    Ljungman, Petter
    Pershagen, Goran
    Andersson, Niklas
    Lindh, Christian
    Georgelis, Antonios
    Kull, Inger
    Melen, Erik
    Ekstrom, Sandra
    Bergstrom, Anna
    BMJ OPEN, 2023, 13 (07):
  • [33] Cross-Cultural Adaptation and Clinical Validation of TIME Criteria to Detect Potentially Inappropriate Medication Use in Older Adults: Methodological Report from the TIME International Study Group
    Bahat, Gulistan
    Erdogan, Tugba
    Can, Busra
    Ozkok, Serdar
    Ilhan, Birkan
    Tufan, Asli
    Karan, Mehmet Akif
    Benetos, Athanase
    Cherubini, Antonio
    Drey, Michael
    Garfinkel, Doron
    Gasowski, Jerzy
    Renom-Guiteras, Anna
    Kotsani, Marina
    Mccarthy, Lisa
    Onder, Graziano
    Pazan, Farhad
    Piotrowicz, Karolina
    Rochon, Paula
    Ruppe, Georg
    Thompson, Wade
    Topinkova, Eva
    van der Velde, Nathalie
    Petrovic, Mirko
    DRUGS & AGING, 2025, 42 (01) : 57 - 67
  • [34] Food Services Using Energy- and Protein-Fortified Meals to Assist Vulnerable Community-Residing Older Adults Meet Their Dietary Requirements and Maintain Good Health and Quality of Life: Findings from a Pilot Study
    Arjuna, Tony
    Miller, Michelle
    Ueno, Tomoko
    Visvanathan, Renuka
    Lange, Kylie
    Soenen, Stijn
    Chapman, Ian
    Luscombe-Marsh, Natalie
    GERIATRICS, 2018, 3 (03)
  • [35] CAN USE OF HIGH COST DRUGS FOR RARE RHEUMATIC DISEASES BE RELIABLY IDENTIFIED WITHIN ROUTINELY COLLECTED NHS DATA? RESULTS FROM A PILOT STUDY OF RITUXIMAB USE IN VASCULITIS USING DATA FROM THE NATIONAL DISEASE REGISTRATION SERVICE (NDRS) AND THE REGISTRATION OF COMPLEX RARE DISEASES - EXEMPLARS IN RHEUMATOLOGY (RECORDER) PROJECT
    Chakravorty, Mithun
    Pearce, Fiona
    Rutter, Megan
    Lanyon, Peter
    Aston, Jeanette
    Bythell, Mary
    Stevens, Sarah
    RHEUMATOLOGY, 2021, 60
  • [36] IDENTIFYING HIGH-COST DRUGS FOR RARE RHEUMATIC DISEASES IN ROUTINELY COLLECTED NHS DATA. RESULTS FROM A PILOT STUDY OF RITUXIMAB USE IN VASCULITIS USING DATA FROM THE NATIONAL DISEASE REGISTRATION SERVICE AND THE REGISTRATION OF COMPLEX RARE DISEASES-EXEMPLARS IN RHEUMATOLOGY (RECORDER) PROJECT
    Godsave, C.
    Chakravorty, M.
    Rutter, M.
    Lanyon, P.
    Aston, J.
    Bythell, M.
    Stevens, S.
    Pearce, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 989 - 990
  • [37] P091 Can use of high cost drugs for rare rheumatic diseases be reliably identified within routinely collected NHS data? Results from a pilot study of rituximab use in vasculitis using data from the National Disease Registration Service (NDRS) and the Registration of Complex Rare Diseases-Exemplars in Rheumatology (RECORDER) project
    Chakravorty, Mithun
    Pearce, Fiona
    Rutter, Megan
    Lanyon, Peter
    Aston, Jeanette
    Bythell, Mary
    Stevens, Sarah
    RHEUMATOLOGY, 2021, 60
  • [38] Risk of Sarcopenia Following Long-Term Statin Use In Community-Dwelling Middle-Aged and Older Adults in Japan: Evidence From a 10-Year Population-Based Cohort Study Using Propensity Score Matching and Overlap Weighting
    Huang, Shih-Tsung
    Otsuka, Rei
    Nishita, Yukiko
    Meng, Lin-Chieh
    Shimokata, Hiroshi
    Hsiao, Fei-Yuan
    Chen, Liang-Kung
    Arai, Hidenori
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 401 - 402